Catalyst Wire Dossier Catalyst Wire Dossier

Indacaterol/glycopyrronium bromide

indacaterol; glycopyrronium bromide · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Indacaterol/glycopyrronium bromide, covering 2016-02-09 to 2016-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. [Phase 3]

See pricing